A phase II trial of Cremorphor EL-free paclitaxel (Genexol-PM) and gemcitabine in patients with advanced non-small cell lung cancer

PURPOSE: Genexol-PM is a Cremorphor EL (CrEL)-free polymeric micelle formulation of paclitaxel that allows higher-dose administration with less hypersensitivity. This study was designed to evaluate the efficacy and safety of Genexol-PM and gemcitabine combination in advanced non-small cell lung canc...

Descripción completa

Detalles Bibliográficos
Autores principales: Ahn, Hee Kyung, Jung, Minkyu, Sym, Sun Jin, Shin, Dong Bok, Kang, Shin Myung, Kyung, Sun Young, Park, Jeong-Woong, Jeong, Sung Hwan, Cho, Eun Kyung
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2014
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4112044/
https://www.ncbi.nlm.nih.gov/pubmed/24906423
http://dx.doi.org/10.1007/s00280-014-2498-5

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4112044/
https://www.ncbi.nlm.nih.gov/pubmed/24906423
http://dx.doi.org/10.1007/s00280-014-2498-5

Ejemplares similares